Medical resource goes wireless http://Merckmedicus.com/ the online medical resource for clinicians, is offering a new wireless browsing format. With this new access method, registered users can use a wireless personal digital assistant (PDA), BlackBerry, or smartphone to remotely access in real-time much of the health information from the Web site http:// http://www.merckmedicus.com/. (Examples of resources are The Merck Manual of Diagnosis and Therapy, 17th Edition; Pocket Guide to Diagnostic Tests, and MEDLINE journal abstracts.) A unique Personal Search Assistant feature will allow physicians to search through current issues of more than 200 journals and tailor them to their specialty or area of interest. Registration on http://Merckmedicus.com/ is free and gives the user complete access to all of the Web site's online content-and wireless access to selected content. The wireless option is compatible with all cellular phones with Web-browsing capabilities, smart phones, and other handheld devices that use Windows Mobile-based Pocket PC, Blackberry, or Palm OS operating systems.
Magnesium for building bone health While telling your patients over age 50 to take calcium may be a key way to reduce their risk of developing osteoporosis and low bone mass, ob/gyns are also becoming increasingly aware of magnesium's role in helping bind calcium to bones and improve bone density, according to Blaine Pharmaceuticals (Fort Wright, Ky.), makers of Mag-Ox 400 magnesium supplement. Common signs and symptoms of magnesium deficiency are leg cramps, migraines, and fatigue, the manufacturer says. The easy-to-swallow tablets contain the most concentrated form of magnesium, are of pharmaceutical-grade quality, and are formulated for optimal absorption. Each tablet of Mag-Ox 400 contains 400 mg of magnesium oxide (which provides 241.3 mg of elemental magnesium). This product is available either behind or over-the-counter at select drug stores. For more information, visit the company Web site at http:// http://www.blainepharma.com/.
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More